These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 22044415)

  • 1. Polymorphisms, hypertension and thiazide diuretics.
    Citterio L; Lanzani C; Manunta P
    Pharmacogenomics; 2011 Nov; 12(11):1587-604. PubMed ID: 22044415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics of primary hypertension: the clinical impact of adducin polymorphisms.
    Citterio L; Lanzani C; Manunta P; Bianchi G
    Biochim Biophys Acta; 2010 Dec; 1802(12):1285-98. PubMed ID: 20382219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adducin- and ouabain-related gene variants predict the antihypertensive activity of rostafuroxin, part 2: clinical studies.
    Lanzani C; Citterio L; Glorioso N; Manunta P; Tripodi G; Salvi E; Carpini SD; Ferrandi M; Messaggio E; Staessen JA; Cusi D; Macciardi F; Argiolas G; Valentini G; Ferrari P; Bianchi G
    Sci Transl Med; 2010 Nov; 2(59):59ra87. PubMed ID: 21106941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adducin polymorphisms and the treatment of hypertension.
    Manunta P; Citterio L; Lanzani C; Ferrandi M
    Pharmacogenomics; 2007 May; 8(5):465-72. PubMed ID: 17465710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valsartan plus hydrochlorothiazide for first-line therapy in hypertension.
    Lacourcière Y; Poirier L; Samuel R
    Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1491-501. PubMed ID: 19954310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrochlorothiazide versus chlorthalidone in the management of hypertension.
    Neff KM; Nawarskas JJ
    Cardiol Rev; 2010; 18(1):51-6. PubMed ID: 20010338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Are all diuretics equal for the treatment of hypertensive patients?].
    Waeber B; Feihl F
    Rev Med Suisse; 2012 Sep; 8(353):1699-701. PubMed ID: 23029982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical predictors of the response to short-term thiazide treatment in nondiabetic essential hypertensives.
    Huang CC; Leu HB; Wu TC; Lin SJ; Chen JW
    J Hum Hypertens; 2008 May; 22(5):329-37. PubMed ID: 18305547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple combination therapy to improve blood pressure control: experience with olmesartan-amlodipine-hydrochlorothiazide therapy.
    Tocci G; Paneni F; Passerini J; Volpe M
    Expert Opin Pharmacother; 2012 Dec; 13(18):2687-97. PubMed ID: 23170911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum selenium levels in diuretic-treated hypertensives: a double-blind trial of piretanide against hydrochlorothiazide plus amiloride.
    Verho M; Bossaller W; Malerczyk V
    Int J Clin Pharmacol Res; 1988; 8(1):5-8. PubMed ID: 3284831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of adducin polymorphism.
    Bianchi G; Manunta P; Glorioso N
    J Hypertens; 2009 Jun; 27(6):1325-7; author reply 1327-9. PubMed ID: 19454906
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chlorthalidone better than hydrochlorothiazide in hypertension].
    Kooter AJ; Smulders YM
    Ned Tijdschr Geneeskd; 2010; 154():A1608. PubMed ID: 20456766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
    Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperlipidemia of diuretic therapy.
    Ames R
    Arch Mal Coeur Vaiss; 1998 Sep; 91 Suppl():23-7. PubMed ID: 9805566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiazide diuretics for hypertension: prescribing practices and predictors of use in 194,761 elderly patients with hypertension.
    Tu K; Campbell NR; Chen Z; McAlister FA
    Am J Geriatr Pharmacother; 2006 Jun; 4(2):161-7. PubMed ID: 16860263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diuretic of choice in ABFM hypertension self-assessment module simulations.
    Hagen MD; Sumner W; Fu H
    J Am Board Fam Med; 2012; 25(6):805-9. PubMed ID: 23136319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics and pharmacogenetics of hypertension: update and perspectives--the adducin paradigm.
    Manunta P; Bianchi G
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S30-5. PubMed ID: 16565244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical testing of a new potassium-saving diuretic for the treatment of hypertension].
    Vetter G
    Munch Med Wochenschr; 1973 Dec; 115(49):2249-50. PubMed ID: 4592408
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential effects of renin-angiotensin-aldosterone system inhibition, sympathoinhibition and diuretic therapy on endothelial function and blood pressure in obesity-related hypertension: a double-blind, placebo-controlled cross-over trial.
    Dorresteijn JA; Schrover IM; Visseren FL; Scheffer PG; Oey PL; Danser AH; Spiering W
    J Hypertens; 2013 Feb; 31(2):393-403. PubMed ID: 23235355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
    Ferguson JM; Minas J; Siapantas S; Komesaroff PA; Sudhir K
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):590-5. PubMed ID: 18520951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.